Phase 1/2 RESTORE-MASH trial will evaluate safety, pharmacokinetics, and pharmacodynamics of TGM-312 in healthy volunteers and MASH ...

Alnylam Pharmaceuticals (NasdaqGS:ALNY) has signed a multi year research collaboration with Tenaya Therapeutics focused on RNAi based therapeutics for cardiovascular diseases. The agreement covers up ...

Discover six RNAi biotech companies helping to drive momentum in a field that can precisely target disease at its genetic root.

Univeristy of Nebraska-Lincoln (UNL) scientist Ana Maria Vélez is pioneering a genetic treatment to contain western corn rootworm. The research seeks to contain agricultural pests by targeting ...

This week's round-up of pharma licensing deals features alliances involving Tenaya Therapeutics, Sino Bio, Antengene, and A2A ...

Johnson & Johnson has presented clinical trial data linking short-term treatment with RNAi therapy JNJ-3989 to sustained reductions in markers of hepatitis B infection. The data drop comes as J&J runs ...

Farmers looking to gain the upper hand over corn rootworm (CRW) pests have new tools to deploy in the field, thanks to Ribonucleic acid interference (RNAi) technology. RNAi works in CRW as it feeds on ...

The ability to turn off a gene of interest in a temporally and spatially controlled manner is key to the analysis of gene function in developing organisms. However, the induction of temporally ...

Double-stranded RNA can be introduced experimentally to silence genes of interest. In plants, silencing can be triggered, for example, by engineering RNA viruses. In worms, silencing can be triggered ...

RNAi is a powerful tool to used to define cellular mechanisms, and analyze the gene functions of various organisms in laboratories worldwide. Credit: petarg/ Shutterstock.com Fragments of RNA ...

When it was discovered over a decade ago, RNAi seemed poised to revolutionize medicine. By working to silence defective genes, it has the potential to treat innumerable diseases. Has it delivered? In ...

With no single headline event setting the tone, Arrowhead Pharmaceuticals (ARWR) is drawing attention as investors weigh its recent share performance against current financial metrics and the breadth ...